It starts, usually, around midnight. A browser tab opens. Then another. Prices appear — £800 here, £2,400 there — and none of the websites quite explain what you're actually paying for. A man in his late forties, recently diagnosed with type 2 diabetes, sits in the glow of his laptop trying to work out whether the Priapus Shot is something real, something worth considering, or something that belongs in the category of expensive placebos dressed up in medical language. He closes the laptop without booking anything.
That hesitation is not weakness. It is, in fact, the right instinct. The problem is knowing what to do with it.
Why Diabetes Changes the Conversation About Erectile Dysfunction
Erectile dysfunction affects a significant proportion of men with diabetes — estimates from urology research suggest that between 35 and 75 per cent of diabetic men will experience some degree of it, often earlier and more severely than men without the condition. The reasons are physiological rather than psychological, though the psychological weight is real enough.
Diabetes damages the small blood vessels and nerves that govern erectile function. Over time, elevated blood glucose levels compromise the endothelial cells that line blood vessel walls, reducing their ability to produce nitric oxide — the molecule responsible for triggering the relaxation of smooth muscle tissue in the penis and the subsequent increase in blood flow that produces an erection. Nerve damage — peripheral neuropathy — compounds the problem, disrupting the signals between the brain and the tissue.
This is not a performance issue. It is a vascular and neurological one. And that distinction matters enormously when choosing a treatment.
PDE5 inhibitors such as sildenafil (the drug class that includes Viagra) work by prolonging the effect of nitric oxide once it is released, but if the vessels themselves are damaged, there may not be enough nitric oxide to work with. This is why a proportion of diabetic men find that oral medications provide diminishing returns over time, and why regenerative approaches have attracted serious clinical interest.
What the P-Shot Actually Does
The Priapus Shot — more commonly called the P-Shot — is a PRP-based treatment. PRP stands for platelet-rich plasma, a concentration derived from the patient's own blood. A sample is drawn, centrifuged to separate the plasma from other blood components, and the resulting platelet-rich fraction is then injected into specific areas of penile tissue.
The mechanism is not hormonal. It works by delivering high concentrations of growth factors — including PDGF, VEGF, and TGF-β — directly into the tissue. These growth factors stimulate angiogenesis (the formation of new blood vessels), activate stem cells, and support the repair of damaged collagen structures. For men whose erectile dysfunction has a vascular or neurological component, as is frequently the case in diabetes, the goal is to address some of the underlying structural damage rather than merely compensating for it pharmacologically.
Realistic expectations are important here. The P-Shot is not a guaranteed cure, and no responsible practitioner should present it as one. Clinical outcomes vary. Some men report meaningful improvement in erectile quality and sensitivity. Others may experience more modest results. The research base, while growing, is not yet at the scale of large randomised controlled trials. The European Association of Urology acknowledges PRP as an area of active investigation in sexual medicine, and several institutional studies — including work published through Cleveland Clinic-affiliated researchers — have shown promising signals in men with organic erectile dysfunction.
What the treatment offers is a biologically coherent approach, with a reasonable safety profile (given that it uses the patient's own blood) and a mechanism that is directly relevant to the kind of damage diabetes causes. That is a meaningful combination.
Why the Price Difference Is Not Random
Return to those browser tabs. The gap between £800 and £2,400 for ostensibly the same treatment is not a matter of branding. It reflects real differences in what is being delivered.
At the lower end of the market, PRP treatments are frequently performed in aesthetic clinics where the primary focus is cosmetic — hair restoration, facial rejuvenation, skin treatments. The practitioners may have limited experience with male sexual medicine specifically. The centrifuge systems used to process the blood vary significantly in quality; non-CE-marked devices produce inconsistent platelet concentrations, which directly affects the quality of the PRP. The injection itself, performed without imaging guidance, relies on manual technique alone.
At the medical end of the market, the differences are substantive. CE-marked centrifuge systems produce PRP within a defined and verifiable concentration range. Ultrasound-guided injection allows the practitioner to visualise the neurovascular bundle in real time, reducing the risk of inadvertent trauma and improving the precision of placement. The consultation includes a proper clinical assessment — not just a form, but a conversation that takes into account the patient's medical history, medications, and the specific nature of his dysfunction.
For a diabetic man, these distinctions are not academic. Diabetes can affect wound healing and vascular integrity in ways that increase procedural risk if the technique is imprecise. The margin for error is smaller, and the value of clinical experience is correspondingly greater.
Before booking any PRP-based treatment, a patient should ask: Is this being performed by a medically qualified practitioner with specific experience in male sexual health? What centrifuge system is used, and is it CE-marked? Will the injection be guided by imaging? Is there a proper pre-treatment consultation?
If a clinic cannot answer these questions clearly, or seems reluctant to engage with them, that is useful information.
What Choosing Well Actually Looks Like
Wimpole Street and the surrounding Marylebone area of London has become a hub for private medical practice in part because it attracts practitioners with serious clinical backgrounds rather than purely aesthetic ones. Dr SNA Clinic, led by Dr Syed Nadeem Abbas — who holds an MRCS and an MSc in Aesthetic Plastic Surgery and trained across Cambridge, Oxford, and the Royal London Hospital — is one of a small number of London practices offering P-Shot treatment within a framework that prioritises the medical rather than the commercial dimension of the procedure. The distinction shows in the consultation model and the protocols used.
This is not about prestige for its own sake. It is about the kind of clinical environment in which a man with a complex underlying condition — diabetes, cardiovascular risk, medication interactions — can have a proper conversation and receive a treatment plan that reflects his actual situation.
The Grounded Takeaway
Men researching the P-Shot for diabetes-related erectile dysfunction are, by and large, not looking for a shortcut. They have usually tried other things. They are asking whether this treatment is worth considering, whether it is safe, and whether any of the clinics offering it can be trusted to deliver it properly.
The answer to the first two questions is cautiously affirmative, with the caveat that outcomes vary and the evidence base is still developing. The answer to the third depends almost entirely on the specifics of the clinic — the practitioner's background, the equipment used, and the rigour of the clinical assessment.
The price gap in this market exists because the quality gap is real. That is not a reason to automatically choose the most expensive option, but it is a reason to ask the right questions before assuming that two treatments with the same name are the same treatment.
The man who closed his laptop at midnight without booking anything was not wrong to hesitate. He was right to want more information before deciding. This is what more information looks like.
Comments
Log in or sign up to join the conversation.